Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
Anti-proliferative activity
Cytotoxicity
Mistletoe
Phytochemistry
Viscum album L.
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
09 Jul 2020
09 Jul 2020
Historique:
received:
10
12
2019
accepted:
16
06
2020
entrez:
11
7
2020
pubmed:
11
7
2020
medline:
16
1
2021
Statut:
epublish
Résumé
Viscum album L. (Santalaceae), commonly known as mistletoe, is a hemiparasitic plant traditionally used in complementary cancer treatment. Its antitumor potential is mostly attributed to the presence of aqueous soluble metabolites; however, the use of ethanol as solvent also permits the extraction of pharmacological compounds with antitumor potential. The clinical efficacy of mistletoe therapy inspired the present work, which focuses on ethanolic extracts (V. album "mother tinctures", MT) prepared from different host trees. Samples from three European subspecies (album, austriacum, and abietis) were harvested, and five different V. album-MT strains were prepared. The following phytochemical analyses were performed: thin layer chromatography (TLC), high-performance liquid chromatography (HPLC) and liquid chromatography-high resolution mass spectrometry (LC-HRMS). The proliferation assay was performed with WST-1 after incubation of tumor (Yoshida and Molt-4) and fibroblast cell lines (NIH/3 T3) with different MT concentrations (0.5 to 0.05% v/v). The cell death mechanism was investigated by flow cytometry (FACS) using Annexin V-7AAD. Chemical analyses of MT showed the presence of phenolic acids, flavonoids and lignans. The MT flavonoid and viscotoxin contents (mg/g fresh weight) were highest in Quercus robur (9.67 ± 0.85 mg/g) and Malus domestica (3.95 ± 0.58 mg/mg), respectively. The viscotoxin isoform proportions (% total) were also different among the VA subspecies with a higher content of A3 in V. album growing on Abies alba (60.57 ± 2.13). The phytochemical compounds as well as the viscotoxin contents are probably related to the antitumor effects of MT. The cell death mechanisms evaluated by colorimetric and FACS methodologies involved necrotic damage, which was host tree-, time- and dose- dependent, with different selectivity to tumor cells. Mother tincture from V. album ssp. abietis was the most effective at inducing in vitro cellular effects, even when incubated at the smallest concentration tested, probably because of the higher content of VT A3. Our results indicate the promising antitumor potential of Viscum album ethanolic extracts and the importance of botanical and phytochemical characterization for in vitro anti-proliferative effects.
Sections du résumé
BACKGROUND
BACKGROUND
Viscum album L. (Santalaceae), commonly known as mistletoe, is a hemiparasitic plant traditionally used in complementary cancer treatment. Its antitumor potential is mostly attributed to the presence of aqueous soluble metabolites; however, the use of ethanol as solvent also permits the extraction of pharmacological compounds with antitumor potential. The clinical efficacy of mistletoe therapy inspired the present work, which focuses on ethanolic extracts (V. album "mother tinctures", MT) prepared from different host trees.
METHODS
METHODS
Samples from three European subspecies (album, austriacum, and abietis) were harvested, and five different V. album-MT strains were prepared. The following phytochemical analyses were performed: thin layer chromatography (TLC), high-performance liquid chromatography (HPLC) and liquid chromatography-high resolution mass spectrometry (LC-HRMS). The proliferation assay was performed with WST-1 after incubation of tumor (Yoshida and Molt-4) and fibroblast cell lines (NIH/3 T3) with different MT concentrations (0.5 to 0.05% v/v). The cell death mechanism was investigated by flow cytometry (FACS) using Annexin V-7AAD.
RESULTS
RESULTS
Chemical analyses of MT showed the presence of phenolic acids, flavonoids and lignans. The MT flavonoid and viscotoxin contents (mg/g fresh weight) were highest in Quercus robur (9.67 ± 0.85 mg/g) and Malus domestica (3.95 ± 0.58 mg/mg), respectively. The viscotoxin isoform proportions (% total) were also different among the VA subspecies with a higher content of A3 in V. album growing on Abies alba (60.57 ± 2.13). The phytochemical compounds as well as the viscotoxin contents are probably related to the antitumor effects of MT. The cell death mechanisms evaluated by colorimetric and FACS methodologies involved necrotic damage, which was host tree-, time- and dose- dependent, with different selectivity to tumor cells. Mother tincture from V. album ssp. abietis was the most effective at inducing in vitro cellular effects, even when incubated at the smallest concentration tested, probably because of the higher content of VT A3.
CONCLUSION
CONCLUSIONS
Our results indicate the promising antitumor potential of Viscum album ethanolic extracts and the importance of botanical and phytochemical characterization for in vitro anti-proliferative effects.
Identifiants
pubmed: 32646417
doi: 10.1186/s12906-020-02987-4
pii: 10.1186/s12906-020-02987-4
pmc: PMC7346636
doi:
Substances chimiques
Antineoplastic Agents
0
Plant Extracts
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
215Subventions
Organisme : Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
ID : 88881.119813/2016-01
Références
Acta Pol Pharm. 2001 Sep-Oct;58(5):373-9
pubmed: 11876445
Biochem J. 2003 Aug 15;374(Pt 1):71-8
pubmed: 12733989
J Evid Based Integr Med. 2018 Jan-Dec;23:2515690X18789628
pubmed: 30051721
Oncol Lett. 2018 Apr;15(4):4657-4661
pubmed: 29552109
Acta Biol Hung. 2013 Sep;64(3):279-88
pubmed: 24013890
Phytomedicine. 1998 Mar;5(1):11-7
pubmed: 23195693
Food Funct. 2016 May 18;7(5):2270-7
pubmed: 27072079
Chem Biol Interact. 2015 Dec 5;242:35-44
pubmed: 26367700
Phytother Res. 2015 Nov;29(11):1737-43
pubmed: 26236010
Molecules. 2017 Apr 12;22(4):
pubmed: 28417943
PLoS One. 2017 Jan 19;12(1):e0170077
pubmed: 28103258
Arzneimittelforschung. 2006 Jun;56(6A):428-34
pubmed: 16927522
Integr Cancer Ther. 2010 Jun;9(2):142-57
pubmed: 20483874
Bioorg Med Chem Lett. 2018 Jan 15;28(2):122-128
pubmed: 29223588
J Nat Prod. 2013 Apr 26;76(4):495-502
pubmed: 23484668
BMC Cancer. 2009 Dec 18;9:451
pubmed: 20021637
Mol Cell Biochem. 2013 Jan;373(1-2):211-6
pubmed: 23099844
J Evid Based Complementary Altern Med. 2014 Jan;19(1):31-5
pubmed: 24647376
Nat Prod Res. 2016;30(4):373-85
pubmed: 25813519
Exp Ther Med. 2017 Jun;13(6):2723-2740
pubmed: 28596809
Talanta. 2016 Jan 15;147:16-27
pubmed: 26592571
Mol Nutr Food Res. 2017 Sep;61(9):
pubmed: 28370954
Molecules. 2016 Feb 23;21(3):245
pubmed: 26907248
Saudi Pharm J. 2018 Mar;26(3):311-322
pubmed: 29556122
Forsch Komplementmed. 2009 Aug;16(4):217-26
pubmed: 19729932
J Altern Complement Med. 2016 Feb;22(2):134-44
pubmed: 26684278
J AOAC Int. 2005 Jul-Aug;88(4):1015-9
pubmed: 16152916
Rapid Commun Mass Spectrom. 2012 May 15;26(9):1123-33
pubmed: 22467463
J Nutr Biochem. 2017 Aug;46:68-73
pubmed: 28458139
Planta Med. 1998 Oct;64(7):677-8
pubmed: 17253311